About

Quality Policy

Our mission at TwoBullMediTherapy, is:
1To offer In-Vitro Diagnostic Medical Devices
through comprehensive and competitive Design, Development and Production declared and evidence based Roadmap, with the highest degree of Accuracy, Efficiency, Efficiency and Safety to every single potential end-user, regardless of their individual financial status, geographical location, and Academic or Training Background.
2To provide validated Innovative Diagnostic Solutions for the Accurate and Early Diagnosis of Aortic Aneurysms
, in a personalised manner for General Population as well as of High-Risk Groups, thus Preventing abrupt eruption of undiagnosed Aneurysms, enhancing the relevant Therapeutic Methodologies by early Intervention, prolonging their individual survival and improving significantly their quality of life
3To develop, manufacture and market solely safe and effective In Vitro Diagnostic products
to applicable specifications and intended uses, that meet fully National and International Standards as well as Applied relevant Regulatory Requirements.
4To meet customers safety and satisfaction criteria and expectations
without contradicting to applied and claimed National and International Standards as well as Regulatory Requirements
5To continuously improve and optimize Company’s Quality Management System.


Excellence in Research

Prof. Ioannis Toumpoulis is the Head of Research & Development of our team. He has shown abundant researching activities consistently from 1995 up to today (23 years), despite his young age. His efficacy in the research sector is considered very high, since he has over 100 announcements/presentations in international conferences and over 80 publications in international scientific peer-reviewed magazines.

He has received 26 awards and disctinctions for his work in Greek and International conferences, and he has received 8 scholarships.

Awards

Marquis Who’s Who in
Science and Engineering.

2006

Evarts A. Graham Memorial Traveling Fellowship 2007-2008

American Association for Thoracic Surgery, 2007.


Edward B. Diethrich Vascular Surgical Society International Traveling Fellow Award.

International Congress XXI Endovascular Interventions. Scottsdale, AZ, USA, 2008.

Marquis Who’s Who in The World.

2008


Award of the Best Research Study.

Study: “Myocardial Protection from Ischemia Reperfusion Injury with Mitochondrial Injection”. 8th National (Panhellenic) Meeting of Thoracic and Cardiovascular Surgeons, Athens, Greece, 2010

Best Oral Presentation Award.

Study: “Differential Expression of Collagen Type V and XI alpha-1 in Human Ascending Thoracic Aortic Aneurysms”. 5th International Meeting of the Onassis Cardiac Surgery Center, Athens, Greece, 2010.


Award of the Best Research Study in Lung Cancer.

Study: “Gene Expression of Collagen Type XI(alpha-1) in Patients with Non-small Cell Lung Cacer Correlates with Prognosis”. 20th National (Panhellenic) Meeting of Thoracic Diseases, Athens, Greece, 2011.

Stavros Niarchos International Guest Scholarship

American College of Surgeons, 2014.

History

  • 2007Research

    The novel mechanism was discovered. It explains how an aneurysm is created and grows and at the same time makes a diagnostic blood test possible.
  • 2016Company establishment

  • 2017Proof of concept

    100 preliminary blood tests prove the concept of the novel mechanism.
  • 2018International Patent

    We applied for acquiring an international patent regarding the novel mechanism that describes the way an aneurysm is created and grows. PCT/EP2018/062897.
  • 2018 - 2019Egg - Enter • Grow • Go

    Participation in the Egg - Enter • Grow • Go program. Egg is a Corporate Social Responsibility initiative of Eurobank, designed and implemented with Corallia. It's one of the largest incubator and accelerator programs in Greece.
  • 2019Funding

    Big Pi Ventures, a seed-stage and technology-transfer fund investing in Greece, member of EIF-Equifund, decided to invest in our company, and in our innovative and unique product.
  • 2020Growing

    Moving towards CE Certification under the IVDR 2017/746 Regulation for the diagnostic blood test that detects the aortic aneurysm.

Our Team